Development of a Novel Imaging Agent for Determining Albumin Uptake in Solid Tumors

Conclusion111In-C4-DTPA bound rapidly to circulating albumin upon injection and showed time-dependent uptake in the tumors demonstrating a potential for clinical application as a companion imaging diagnostic for albumin-binding anticancer drugs.

Source: Nuclear Medicine and Molecular Imaging - February 20, 2019 Category: Nuclear Medicine Source Type: research